Investors

Upcoming results

We will announce our first quarter 2026 results on Wednesday 29 April.

FY 2025 results Annual Report 2025

We’re confident in our future

With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide.

Why invest in GSK?

BNP Paribas Healthcare Conference

Access all speeches and presentations

24 March 2026

Julie Brown, Chief Financial Officer, attended the BNP Paribas Healthcare Conference in London on Tuesday, 24 March 2026.

Barclays 28th Annual Global Healthcare Conference

Access all speeches and presentations

11 March 2026

David Redfern, President Corporate Development, participated in a fireside chat at the Barclays 28th Annual Global Healthcare Conference in Miami, FL on Wednesday, 11 March 2026 at 11:30 am EST/4:30 pm GMT.

Leerink Partners Global Healthcare Conference

Access all speeches and presentations

10 March 2026

David Redfern, President Corporate Development, attended the Leerink Partners Global Healthcare Conference in Miami, FL on Tuesday, 10 March 2026.

UBS European Healthcare Conference

Access all speeches and presentations

04 March 2026

David Redfern, President Corporate Development, attended the UBS European Healthcare Conference in London on Wednesday, 4 March 2026.

GSK enters agreement to acquire 35Pharma Inc.

Access all speeches and presentations

25 February 2026

Sell-side analysts calls with Nina Mojas, President, Global Product Strategy and Kaivan Khavandi, SVP, R&D Head, Respiratory, Immunology & Inflammation.

Shareholder information

GSK dividend

GSK share price

Share price tool

Detailed information on GSK's share price, including an interactive chart

Go to share price tool

Behind the Science

Read our latest articles

Antibody-drug conjugates: Advancing the search for more targeted cancer treatment

Mapping disease at the cellular level: A single-cell revolution in drug discovery

Why adults aged 50 years and older with certain long-term health conditions need to make their move to help protect against this common respiratory virus

'The ever-present threat of contracting a UTI means my daily routine is ruled by measures to reduce my risk'

'We’re innovating to help keep COPD patients out of hospital and exacerbation-free'

'Prevention is the best medicine to stop disease before it starts'

‘I was the sickest anyone could ever be’: Why young people are at risk of meningitis and what needs to change to reduce it

‘Digital biological twins and organoids might sound like sci-fi, but they’re real – and we’re using them to fight cancer’

‘I feel hopeless and frustrated’: Why patients living with incurable blood cancers need more treatment options

‘Finding the right treatment for my asthma and nasal polyps has transformed my life. I hope my experience can help others achieve the same’

Behind the Science magazine

Investors

Upcoming results

We’re confident in our future

Speeches and presentations

BNP Paribas Healthcare Conference

Barclays 28th Annual Global Healthcare Conference

Leerink Partners Global Healthcare Conference

UBS European Healthcare Conference

GSK enters agreement to acquire 35Pharma Inc.

Shareholder information

GSK dividend

GSK share price

Share price tool

Read our latest articles

Antibody-drug conjugates: Advancing the search for more targeted cancer treatment

Mapping disease at the cellular level: A single-cell revolution in drug discovery

Why adults aged 50 years and older with certain long-term health conditions need to make their move to help protect against this common respiratory virus

'The ever-present threat of contracting a UTI means my daily routine is ruled by measures to reduce my risk'

'We’re innovating to help keep COPD patients out of hospital and exacerbation-free'

'Prevention is the best medicine to stop disease before it starts'

‘I was the sickest anyone could ever be’: Why young people are at risk of meningitis and what needs to change to reduce it

‘Digital biological twins and organoids might sound like sci-fi, but they’re real – and we’re using them to fight cancer’

‘I feel hopeless and frustrated’: Why patients living with incurable blood cancers need more treatment options

‘Finding the right treatment for my asthma and nasal polyps has transformed my life. I hope my experience can help others achieve the same’

You might also like

Investors

Upcoming results

We’re confident in our future

Stock exchange announcements

Quarterly results

Analyst consensus

Financial reports

Speeches and presentations

BNP Paribas Healthcare Conference

Barclays 28th Annual Global Healthcare Conference

Leerink Partners Global Healthcare Conference

UBS European Healthcare Conference

GSK enters agreement to acquire 35Pharma Inc.

Shareholder information

GSK dividend

Dividend calculators (GBp/USD)

Dividend calendar

GSK share price

Share price tool

Read our latest articles

Antibody-drug conjugates: Advancing the search for more targeted cancer treatment

Mapping disease at the cellular level: A single-cell revolution in drug discovery

Why adults aged 50 years and older with certain long-term health conditions need to make their move to help protect against this common respiratory virus

'The ever-present threat of contracting a UTI means my daily routine is ruled by measures to reduce my risk'

'We’re innovating to help keep COPD patients out of hospital and exacerbation-free'

'Prevention is the best medicine to stop disease before it starts'

‘I was the sickest anyone could ever be’: Why young people are at risk of meningitis and what needs to change to reduce it

‘Digital biological twins and organoids might sound like sci-fi, but they’re real – and we’re using them to fight cancer’

‘I feel hopeless and frustrated’: Why patients living with incurable blood cancers need more treatment options

‘Finding the right treatment for my asthma and nasal polyps has transformed my life. I hope my experience can help others achieve the same’

You might also like

Pipeline

Our leading scientists

Governance